documents: FDA-2022-D-0745-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-D-0745-0002 FDA FDA-2022-D-0745 Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies; Draft Guidance for Industry Other Guidance 2022-06-16T04:00:00Z 2022 6 2022-06-16T04:00:00Z 2022-09-15T03:59:59Z 2023-11-28T19:57:36Z   0 0 090000648516e048

Links from other tables